Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?

Core Viewpoint - West Pharmaceutical Services (WST) has seen a 7.3% increase in share price over the past four weeks, closing at $216.64, with a potential upside of 31.1% based on Wall Street analysts' mean price target of $284 [1] Price Targets and Analyst Consensus - The average of 10 short-term price targets ranges from a low of $245 to a high of $355, with a standard deviation of $34.94, indicating variability in estimates [2] - The lowest estimate suggests a 13.1% increase, while the highest points to a 63.9% upside, highlighting the range of analyst expectations [2] - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about WST's earnings prospects, as evidenced by a trend of higher EPS estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 1.9% over the past month, with five estimates increasing and no negative revisions [12] - WST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13]